US equities
|
MU
$1,045.56
▲+0.00%
INTC
$112.50
▲+0.00%
NVDA
$239.24
▲+0.00%
SNDK
$1,660.46
▲+0.00%
SPCX
$171.92
▲+0.00%
MRVL
$287.01
▲+0.00%
AMD
$649.42
▲+0.00%
MSTR
$164.55
▲+0.00%
MU
$1,045.56
▲+0.00%
INTC
$112.50
▲+0.00%
NVDA
$239.24
▲+0.00%
SNDK
$1,660.46
▲+0.00%
SPCX
$171.92
▲+0.00%
MRVL
$287.01
▲+0.00%
AMD
$649.42
▲+0.00%
MSTR
$164.55
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about Dave Mehalick
Recent news which mentions Dave Mehalick
Coeptis appoints Colleen Delaney as chief scientific and medical officer
September 05, 2023
Tickers
INNO
Tags
Technology
Dave Mehalick
Biotech
From
Business Journals
Coeptis Therapeutics pursuing possible acquisition of cell therapy platform
March 29, 2023
Tickers
INNO
Tags
Insurance
Biotech
Health Care
From
Business Journals
Wexford pharmaceutical company acquires technologies
August 19, 2021
Tags
Pharmaceuticals
Health Care
Insurance
From
Business Journals